Helene M. Markkanen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Helene M. Markkanen has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Henrik Alfthan
Helsinki University Central Hospital, HUSLAB, Helsinki, Finland
2 shared publicationsTuula Pekkarinen
HUS Abdominal Centre, Endocrinology, Helsinki University Hospital, Helsinki, Finland
2 shared publicationsEsa Hämäläinen
Helsinki University Central Hospital, HUSLAB, Helsinki, Finland; Department of Clinical Chemistry, Helsinki University Central Hospital, Helsinki, Finland
1 shared publicationMatti J Välimäki
Department of Clinical Chemistry and Division of Endocrinology, Department of Medicine, Helsinki University Hospital, Helsinki, Finland
1 shared publicationMatti J. Välimäki
HUS Abdominal Centre, Endocrinology, Helsinki University Hospital, Helsinki, Finland
1 shared publicationRitva Kauppinen-Mäkelin
Department of Internal Medicine, Jorvi Hospital, Espoo, Finland
1 shared publication
Latest Publications
- 1 August 2017
- Published by Elsevier in Growth Hormone & IGF Research
- Vol. 35, 52-56
Gender has to be taken into account in diagnosing adult growth hormone deficiency by the GHRH plus arginine test
- 1 August 2017
- Published by Elsevier in Growth Hormone & IGF Research
- Vol. 35, 52-56
Gender has to be taken into account in diagnosing adult growth hormone deficiency by the GHRH plus arginine test
- Open Access
- 1 March 2006
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 52 (3) , 468-473
Effect of Sex and Assay Method on Serum Concentrations of Growth Hormone in Patients with Acromegaly and in Healthy Controls
Background: Diagnosis and follow-up of acromegaly is based on measurements of serum growth hormone (GH) concentrations during an oral glucose tolerance test (OGTT). A nadir value <1 μg/L is commonly used to define a normal response, but some authors suggest lower cutoff values.
- 1 March 2006
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 52 (3) , 468-473
Open AccessEffect of Sex and Assay Method on Serum Concentrations of Growth Hormone in Patients with Acromegaly and in Healthy Controls
Background: Diagnosis and follow-up of acromegaly is based on measurements of serum growth hormone (GH) concentrations during an oral glucose tolerance test (OGTT). A nadir value <1 μg/L is commonly used to define a normal response, but some authors suggest lower cutoff values.